Trials / Completed
CompletedNCT05090618
The Role of Genetic Factors in the Development of Myocardial Infarction in the Kazakh Population
Preventive and Personalized Medicine (2021-2023)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (actual)
- Sponsor
- Asfendiyarov Kazakh National Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This is a GWAS study that aims to identify possible candidate genes associate to heart attack by exploring single nucleotide polymorphism (SNP) in a group of heart attack, in the Kazakh population. The investigators hypothesize that the careful phenotyping of the subject sand matching with increase the power to find SNP significantly associate with heart attack
Detailed description
A genome-wide association study (GWAS) is an approach used in genetics research to associate specific genetic variations with particular diseases. The method involves scanning the genomes from many different people and looking for genetic markers that can be used to predict the presence of a disease. Once such genetic markers are identified, they can be used to understand how genes contribute to the disease and develop better prevention and treatment strategies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | DNA analysis | GWAS |
Timeline
- Start date
- 2021-10-23
- Primary completion
- 2023-01-20
- Completion
- 2023-01-20
- First posted
- 2021-10-25
- Last updated
- 2023-03-14
Locations
1 site across 1 country: Kazakhstan
Source: ClinicalTrials.gov record NCT05090618. Inclusion in this directory is not an endorsement.